Autoimmune regulator expression in thymomas with or without autoimmune disease

Area of Science:

• Immunology
• Endocrinology
• Oncology

Background:

• The autoimmune regulator (AIRE) protein controls self-antigen expression in the thymus, crucial for preventing autoimmunity.
• Regulatory T cells (Tregs) play a dual role in immune tolerance and potentially promoting tumor growth.
• Thymomas, tumors of the thymus, are often associated with autoimmune conditions.

Purpose of the Study:

• To investigate the expression levels of AIRE, AchR, and Foxp3 in thymoma tissues.
• To correlate these expression levels with clinical conditions such as myasthenia gravis (MG) and other autoimmune diseases (AD).

Main Methods:

• Quantitative RT-PCR and immunohistochemistry were used to measure AIRE, AchR, and Foxp3 mRNA and protein levels in 79 thymoma samples.
• Flow cytometry analyzed peripheral blood Tregs (CD4+CD25+Foxp3+).
• Patients were categorized into simple thymoma (Tm), MG, and MG with AD groups.

Main Results:

• MG and AD groups showed significantly lower AIRE and AchR mRNA levels compared to the simple thymoma group.
• Foxp3 mRNA levels were highest in the simple thymoma group and lowest in the MG and AD groups.
• Positive correlations were observed between AIRE, AchR, and Foxp3 mRNA levels. Thymoma subtypes A/AB/B1 had higher AIRE and AchR levels than B2/B3/C subtypes.

Conclusions:

• Reduced expression of AIRE, AchR, and Foxp3 is associated with thymoma-related autoimmune diseases.
• These findings highlight the role of AIRE and Tregs in thymoma pathogenesis and associated autoimmunity.